00-046
Phase 3 Completed
4,952 enrolled
GRECCAR8
Phase 3 Completed
5 enrolled
MTM-COLON-II
Phase 3 Completed
21 enrolled
RIFIONA
Phase 3 Completed
320 enrolled
FIDURA
Phase 3 Completed
354 enrolled
Néofirinox
Phase 3 Completed
461 enrolled
COLORII
Phase 3 Completed
1,044 enrolled
GRECCAR12
Phase 3 Completed
218 enrolled
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Phase 3 Completed
69 enrolled 9 charts
NACRE
Phase 3 Completed
103 enrolled
CAIRO4
Phase 3 Completed
206 enrolled
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Phase 3 Completed
572 enrolled
Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
Phase 3 Completed
750 enrolled
GRECCAR1
Phase 3 Completed
207 enrolled
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Phase 3 Completed
500 enrolled
GASVERT
Phase 3 Completed
744 enrolled
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Phase 3 Completed
463 enrolled 17 charts
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Phase 3 Completed
362 enrolled 17 charts
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Phase 3 Completed
1,010 enrolled 22 charts
GRECCAR6
Phase 3 Completed
265 enrolled
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
Phase 3 Completed
1,198 enrolled
SURVEILLANCE
Phase 3 Completed
1,997 enrolled
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer
Phase 3 Completed
173 enrolled
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
460 enrolled
BIOPEX
Phase 3 Completed
104 enrolled 8 charts
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
Phase 3 Completed
598 enrolled
RectumSIB
Phase 3 Completed
156 enrolled
Rektum-III
Phase 3 Completed
401 enrolled
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer
Phase 3 Completed
486 enrolled 13 charts
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Completed
1,691 enrolled
Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
Phase 3 Completed
67 enrolled
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Phase 3 Completed
1,168 enrolled
ACP
Phase 3 Completed
8,094 enrolled 23 charts
Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer
Phase 3 Completed
336 enrolled
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
Phase 3 Completed
225 enrolled 12 charts
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Phase 3 Completed
1,053 enrolled 25 charts
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Phase 3 Completed
6,088 enrolled
NERATEM
Phase 3 Completed
25 enrolled
GRECCAR 2
Phase 3 Completed
148 enrolled
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Phase 3 Completed
847 enrolled 21 charts
CPTD
Phase 3 Completed
200 enrolled
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Phase 3 Completed
855 enrolled
MTM-COLON-I
Phase 3 Completed
11 enrolled
PETACC-6
Phase 3 Completed
1,094 enrolled
Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma
Phase 3 Completed
24 enrolled
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Phase 3 Completed
2,025 enrolled
Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Phase 3 Completed
700 enrolled
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Phase 3 Completed
1,011 enrolled
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
Phase 3 Completed
264 enrolled